J&J's Invega Will Launch In January As Follow-On To Risperdal

Paliperidone is the first atypical antipsychotic to be approved since 2003.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet